Compare · head to head
Samsung Biologics vs WuXi AppTec
WuXi AppTec ranks higher overall — 360 rank 99 vs 90.
WuXi AppTec leads on Value (65 vs 36) and Growth (79 vs 74). Samsung Biologics leads on Sentiment (56 vs 48). The two are close on Quality and Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | China |
| Sector | Health Care | Health Care |
| Industry | Life Sciences Tools & Services | Life Sciences Tools & Services |
| Size | Small | X-Large |
| ISIN | KR7207940008 | CNE1000031K4 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 90 | 99 |
| Value | 36 | 65 |
| Quality | 65 | 62 |
| Growth | 74 | 79 |
| Safety | 64 | 66 |
| Sentiment | 56 | 48 |
| Quality details | ||
| Profitability | 87 | 88 |
| Cash Truth | 43 | 37 |
Samsung Biologics vs WuXi Biologics (Cayman)Samsung Biologics vs FuSheng PrecisionSamsung Biologics vs FujifilmSamsung Biologics vs AjinomotoAdd a third stock →
Full analyses: Samsung Biologics · WuXi AppTec
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100